Series B - Cognito Therapeutics - 2024-01-29 - Crunchbase

Cognito Therapeutics raised $35000000 on 2024-01-29 in Series B. FoundersX Ventures FoundersX Ventures, a cross-stage venture capital firm based in Menlo Park with focus on AI …


Install CouponFollow Chrome Extension   CouponFollow Extension

$35000000
OFF

Series B - Cognito Therapeutics - 2024-01-29 - Crunchbase

6 days from now

Cognito Therapeutics raised $35000000 on 2024-01-29 in Series B. FoundersX Ventures FoundersX Ventures, a cross-stage venture capital firm based in Menlo Park with focus on AI …

crunchbase.com

$35
OFF

Cognito Nets $35 Million To Advance Alzheimer's DTx Trial

6 days from now

Jan 29, 2024  · Cognito Therapeutics has raised $35 million to advance its digital therapeutic (DTx) for Alzheimer's disease, the company's CEO Brent Vaughan told FirstWord HealthTech …

firstwordhealthtech.com

$227
OFF

Cognito Therapeutics - Raised $227M Funding From 6 Investors

6 days from now

Oct 29, 2024  · Cognito Therapeutics has raised a total funding of $227M over 5 rounds from 6 investors. Investors include Morningside, FoundersX Ventures and 4 others. ... October 29, …

tracxn.com

$35
OFF

Cognito Raises $35M, Launches Alzheimer’s Biomarker Study

6 days from now

Feb. 1, 2024. By Annette Boyle. Cognito Therapeutics Inc. closed a $35 million extension to the series B fundraising round it started in 2023, bringing the total for the round to $108 million and …

bioworld.com

$35
OFF

Cognito Therapeutics Raises $35M Series B Extension

6 days from now

Jan 30, 2024  · Cognito Therapeutics raises $35M Series B extension. January 30, 2024. 110. Linkedin. Twitter. Facebook. Alzheimer’s disease affects nearly 6 million Americans. It’s the …

gsmedtech.com

$73
OFF

Cognito Therapeutics Scores $73m Series B - Venture Capital Journal

6 days from now

Mar 22, 2023  · The funding will advance Cognito’s study of its non-invasive neuromodulation device. Cambridge, Massachusetts-based Cognito Therapeutics, a neurotechnology company …

venturecapitaljournal.com

$118.25
OFF

Cognito Therapeutics Stock Price, Funding, Valuation, Revenue ...

6 days from now

Jul 2, 2024  · Funding, Valuation & Revenue. Cognito Therapeutics has raised $118.25M over 5 rounds. Cognito Therapeutics's latest funding round was a Series B - III for $10.25M on July 2, …

cbinsights.com

$73
OFF

Cognito Therapeutics Raises $73M Series B To Advance …

6 days from now

Mar 22, 2023  · CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cognito Therapeutics, a neurotechnology company advancing disease-modifying therapies to treat CNS diseases, …

businesswire.com

$73
OFF

Series B - Cognito Therapeutics - 2023-03-22 - Crunchbase

6 days from now

Mar 22, 2023  · Built In Boston — Cognito Raises $73M to Combat Alzheimer’s Disease. News • Mar 22, 2023. Business Wire — Cognito Therapeutics Raises $73M Series B to Advance …

crunchbase.com

$73
OFF

Firm Advises Cognito Therapeutics On $73 Million Series B Financing

6 days from now

Mar 31, 2023  · On March 22, 2023, neurotechnology company Cognito Therapeutics announced a $73 million Series B financing round. The financing was led by FoundersX Ventures with …

wsgr.com

$20
OFF

Cognito Therapeutics Company Profile 2024: Valuation, Funding ...

6 days from now

1. Early Stage VC (Series A) 18-Jul-2016. $20M. $20M. Completed. Pre-Clinical Trials. To view Cognito Therapeutics’s complete valuation and funding history, request access ».

pitchbook.com

$73000000
OFF

Founder Lodge | Cognito Therapeutics, Inc. Raises $73,000,000 At …

6 days from now

Mar 23, 2023  · Cognito Therapeutics, Inc. raises $73,000,000 at Series B on 2023-03-23 in Medical Equipment Manufacturing, industry founded/co-founded by Brent Vaughan Daily …

founderlodge.com

$73
OFF

The Week’s 10 Biggest Funding Rounds: Benefits Startup Gravie …

6 days from now

Mar 24, 2023  · Founded in 2021, this is Artera’s first outside funding round, per Crunchbase data. 6. Cognito Therapeutics, $73M, biotech: Cambridge, Massachusetts-based Cognito …

crunchbase.com

$33056380
OFF

Series B - Enterprise Therapeutics - 2024-01-29 - Crunchbase

6 days from now

Jan 29, 2024  · Enterprise Therapeutics raised $33056380 on 2024-01-29 in Series B. Search Crunchbase. Start Free Trial ... Save . Summary. Overview. Edit Overview Section. …

crunchbase.com

FAQs about Series B - Cognito Therapeutics - 2024-01-29 - Crunchbase Coupon?

Does Cognito therapeutics have a series B financing?

CAMBRIDGE, Mass.-- ( BUSINESS WIRE )-- Cognito Therapeutics, a neurotechnology company advancing disease-modifying therapies to treat CNS diseases, announced today a $73M Series B financing round led by FoundersX Ventures with participation from all existing investors. ...

How did the biotech sector perform in the first quarter of 2024?

The first quarter of 2024 saw a flurry of funding activity in the biotech sector, with early-to-mid-stage companies attracting most of the investment dollars. Among the most notable late-stage deals was blood-based cancer diagnostics firm Freenome ‘s $254 million Series E round. ...

How much funding did biotech companies get in Q1 2024?

To read more on the top biotech firms receiving funding in the quarter, check out 20 biotech startups attracted almost $3B in Q1 2024 funding. Funding totals were fairly diversified across company types. The companies were split into five clusters: ...

Is Cognito a non-invasive neuromodulation device?

Its non-invasive neuromodulation platform was developed by MIT Professors and scientific founders Li-Huei Tsai and Ed Boyden. The Company’s lead therapy is currently in a pivotal study in Alzheimer’s Disease and was awarded FDA Breakthrough Device Designation. Cognito is based in Cambridge, MA. ...

Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension